Table of Contents
Federal enforcement around Medicare Advantage risk adjustment and billing has ramped up over the past two years, producing multimillion-dollar settlements with insurers, provider groups, and the vendors that handle their diagnosis coding, together forming a striking pattern of Medicare Advantage fraud settlements 2026 has already seen accumulate to nearly $1 billion in combined value.
How These Medicare Advantage Fraud Settlements 2026 Were Resolved
The combined value of the settlements comes to nearly $1 billion, though some amounts were structured around the defendants’ ability to pay. In each case the settlements resolved allegations only, and none of the organizations admitted wrongdoing.
Monogram Health’s Recent Settlement
Monogram Health, a Tennessee-based in-home care provider, agreed Aug. 24 to pay $2.4 million to settle allegations that it caused the submission of false diagnosis codes to boost MA payments. The codes fell under four Hierarchical Condition Categories: protein-calorie malnutrition, substance use disorder, coagulation defects and angina pectoris.
Complete Health and Matrix Medical Network Within These Medicare Advantage Fraud Settlements 2026
Complete Health agreed Aug. 3 to pay $14.1 million to resolve allegations it caused false diagnosis codes to be submitted to inflate MA risk-adjustment payments between 2020 and 2023.
The Matrix Medical Network and HealthFair Settlement
Matrix Medical Network, HealthFair, and founder James Ekbatani agreed June 3 to pay a combined $56.5 million to resolve allegations they submitted false diagnosis codes to inflate Medicare Advantage payments. The government said Matrix caused MA plans to submit unsupported diagnoses including atrial fibrillation, rheumatoid arthritis, and COPD between 2014 and 2019, while HealthFair’s alleged conduct from 2015 to 2017 involved diagnoses such as HIV/AIDS, metastatic cancer, and congestive heart failure. HealthFair was acquired by Matrix in 2018 and shut down by 2020.
Aetna’s Settlement Within These Medicare Advantage Fraud Settlements 2026
Aetna agreed March 10 to pay $117.7 million to resolve allegations it submitted or failed to withdraw inaccurate diagnosis codes to inflate its MA payments. The largest portion, $106.2 million, stems from a 2015 chart review program, while $11.5 million resolves allegations tied to morbid obesity codes submitted between 2018 and 2023. A whistleblower who worked as a risk-adjustment coding auditor at the company will receive about $2 million.
Kaiser Permanente’s Record-Setting Settlement
Kaiser Permanente agreed Jan. 14 to pay $556 million, the largest Medicare Advantage fraud settlement to date, to resolve allegations it submitted unsupported diagnosis codes to boost risk-adjusted payments. The government alleged that from 2009 to 2018 in California and Colorado, Kaiser pressured physicians to add diagnoses to patient records after visits had already occurred. The five Kaiser affiliates did not admit wrongdoing, and the whistleblowers will receive roughly $95 million.
Seoul Medical Group and Independent Health Among These Medicare Advantage Fraud Settlements 2026
Seoul Medical Group and Renaissance Imaging Medical Associates agreed March 26, 2025 to pay a combined $62.85 million to resolve allegations they submitted false spinal diagnosis codes to inflate Medicare Advantage payments. Prosecutors said that from 2015 to 2021, Seoul submitted diagnoses for spinal enthesopathy and sacroiliitis that patients did not have, and that Renaissance created false radiology reports to support them.
Independent Health and DxID’s Settlement
Independent Health and DxID agreed Dec. 20, 2024 to pay up to $100 million to resolve allegations that the now-defunct DxID retroactively mined medical records to add diagnoses that inflated MA risk scores. The case closed a roughly 12-year whistleblower lawsuit, and Independent Health did not admit wrongdoing.
Oak Street Health Rounds Out These Medicare Advantage Fraud Settlements 2026
Oak Street Health agreed Sept. 18, 2024 to pay $60 million to resolve allegations it violated the False Claims Act by paying kickbacks to third-party insurance agents to recruit seniors to its primary care clinics. Through a program called the Client Awareness Program, the company paid agents roughly $200 per MA beneficiary referred between September 2020 and December 2022. CVS Health purchased Oak Street in 2023.
A Common Thread Across These Eight Settlements
Across all eight cases, the underlying theme is consistent: organizations across the Medicare Advantage ecosystem, insurers, provider groups, coding vendors, and imaging companies, have all faced enforcement action tied to inflating risk-adjusted payments or, in Oak Street’s case, improper patient recruitment practices, suggesting federal scrutiny extends across nearly every layer of the MA value chain.
What This Pattern of Medicare Advantage Fraud Settlements 2026 Means Going Forward
With settlements ranging from Monogram Health’s $2.4 million to Kaiser Permanente’s record $556 million, and combined value approaching $1 billion, this pattern suggests federal enforcement against Medicare Advantage risk adjustment fraud has become a sustained, rather than isolated, priority for the Department of Justice and whistleblower attorneys. Given that whistleblowers in the Kaiser and Aetna cases alone received a combined $97 million, the financial incentive structure underlying the False Claims Act appears to be generating a steady pipeline of new cases across the industry.
What to Watch Going Forward
As federal enforcement around Medicare Advantage billing and risk adjustment continues, industry observers will likely watch whether additional insurers, provider groups, or coding vendors face similar allegations, particularly given how consistently these settlements have emerged across different segments of the MA ecosystem over the past two years. Given the substantial whistleblower payouts already awarded in several of these cases, this pattern of Medicare Advantage fraud settlements 2026 and prior years may continue incentivizing additional whistleblower lawsuits that could produce further high-value settlements in the months ahead.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
